Unlock instant, AI-driven research and patent intelligence for your innovation.

Preparation and application of human interleukin-6 receptor (hIL6R)-resistant antibody with high affinity

A kind of affinity and antibody technology, applied in the field of biomedicine, can solve the problems of large vacancies in the global market

Inactive Publication Date: 2013-04-24
SINO CELL TECH INC
View PDF1 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, only one company currently has hIL6R antibody drugs on the market, and there is a large gap in the global market
However, there is no related product on the market in my country at present, so there is an urgent need to develop hIL6R antibody drugs to fill the domestic gap

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation and application of human interleukin-6 receptor (hIL6R)-resistant antibody with high affinity
  • Preparation and application of human interleukin-6 receptor (hIL6R)-resistant antibody with high affinity
  • Preparation and application of human interleukin-6 receptor (hIL6R)-resistant antibody with high affinity

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] Example 1, Preparation of hIL6R Mouse Monoclonal Antibody

[0016] 1. Preparation of hIL6R mouse monoclonal antibody

[0017] 1) Animal immunization: In order to obtain a mouse monoclonal antibody that can recognize hIL6R protein, the invention uses the recombinant hIL6R extracellular domain fragment produced by Beijing Yiqiao Shenzhou Biotechnology Co., Ltd. as an immunogen to immunize Balb / c mice. Rats were immunized with 50 μg. For the first immunization, the immunogen and the same amount of complete Freund's adjuvant were used to make an emulsifier, and the abdomen was injected subcutaneously at multiple points, and the same dose of immunogen and the same amount of incomplete Freund's adjuvant were used to make an emulsifier at intervals of 3 weeks , boosted immunization twice, measured serum titer after three times of immunization, took mice with high serum titer and boosted intraperitoneal immunization once with immunogen, and took spleen 3 days later for fusion. ...

Embodiment 2

[0020] Example 2, Screening and identification of antibodies

[0021] After obtaining multiple strains of hIL6R mouse monoclonal antibodies, the antibodies were initially identified and screened, including the identification of antibody affinity and the detection of neutralizing activity:

[0022] Identification of antibody affinity: preliminary identification of antibody affinity was performed on the obtained mouse monoclonal antibody, and the affinity of the screened antibody was verified using Octet biomolecular interaction analyzer, and the hIL6R single Affinity determination of cloned antibodies. The material used therein is biotin-labeled recombinant hIL6R protein at a concentration of 30 μg / ml. After exploring the conditions, the antibody was diluted to 4 different concentrations, 3.33nM, 1.67nM, 0.8333nM and 0.4167nM. By comparing the affinity of each antibody, the antibody with better affinity is selected.

[0023] Antibody neutralization activity detection: Antibo...

Embodiment 3

[0031] Example 3, Obtaining of Monoclonal Antibody Genes

[0032] Hybridoma cells in good condition were collected, total RNA was extracted by adding TRIzol, the quality was detected by electrophoresis, and the concentration was determined by UV. The RNA was then reverse-transcribed into cDNA using a commercial kit, and frozen at -20°C for future use. According to references (Ying W et al., BMC Bioinformatics.2006; 7(Suppl 4): S9), primers were designed using technical schemes known to professionals in the field, and the light chain and heavy chain of the antibody were respectively obtained by PCR using cDNA as a template fragment. The light chain and heavy chain fragments were inserted into the pcDNA3T vector to construct pcDNA3-anti-hIL6R-L and pcDNA3-anti-hIL6R-H vectors. Transform Escherichia coli, pick positive clones, perform sequencing identification, analyze the sequencing results, and obtain the correct light chain and heavy chain amino acid sequences.

[0033] Det...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a human interleukin-6 receptor (hIL6R) monoclonal antibody with high affinity. The antibody can perform a specific recognition on a restructured hIL6R protein so as to effectively block the combination of the restructured hIL6R and the restructured IL6. A double-resistant sandwich enzyme-linked immune detection method established on the basis of the antibody can be used for the specific detection of the IL6R. The antibody can perform the specific recognition of the hIL6R on a cell membrane so as to effectively block the combination of the hIL6R and the IL6 on a cell, thereby preventing cell proliferation from being induced, i.e. the cell proliferation inhibition effect is realized. As a result, the antibody provided by the invention can be used as a candidate antibody for further development of clinical therapeutic medicines.

Description

technical field [0001] The invention relates to the technical field of biomedicine, and relates to the preparation and application of a human interleukin 6 receptor (hIL6R) high-affinity neutralizing active antibody. Background technique [0002] Human interleukin-6 (human interleukin-6, hIL6) is a cytokine with multiple immune regulation functions and has a wide range of biological functions. It can be produced by T lymphocytes, B lymphocytes, fibroblasts, endothelial cells, giant cells, phagocytes and cardiomyocytes. hIL6 conducts its biological activity through two proteins on cells, one is human interleukin-6 receptor (hIL6R), and the other is gp130 protein with a molecular weight of 130KD. hIL6 and hIL6R associate to form a binary complex, which in turn interacts with membrane-bound gp130, which then induces signaling. [0003] hIL6R can be divided into cell membrane-bound and soluble hIL6R (human soluble interleukin-6 receptor, hsIL6R) two types. Cell membrane-bound...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K16/28A61K39/395A61P29/00A61P19/04A61P17/06A61P37/02A61P35/00G01N33/53G01N33/577
Inventor 谢良志张杰赵静孙春昀贺正颖胡萍王加兰李莉
Owner SINO CELL TECH INC